pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Dermatology · news · pharmadog
← back to Dermatology
News · Dermatology
226
stories
Jul 29, 26
7 companies hiring in New York now
biospace
Jul 29, 26
STAT+: FDA expert panel recommends against approval of Capricor’s Duchenne drug
stat
Jul 29, 26
Opinion: The VA could help America win the biotechnology race with China
stat
Jul 29, 26
STAT+: In the biotech industry, a most-wanted fugitive was long hiding in plain sight
stat
Jul 28, 26
STAT+: American Diabetes Association, facing calls for resignations, asks for patience
stat
Jul 28, 26
STAT+: GSK lays out plans to cut costs, pursue more late-stage drug trials
stat
Jul 28, 26
STAT+: FDA staff reiterate concerns about Replimune skin cancer treatment
stat
Jul 28, 26
Altimmune rises as GLP-1/glucagon drug curbs heavy drinking in mid-stage study
biospace
Jul 28, 26
After PCOS became PMOS, there’s hope for new awareness among Black and Latina women
stat
Jul 27, 26
Argenx to acquire Forte in $2.2B deal for ‘differentiated’ immune drug
biopharma dive
Jul 27, 26
InnoCare’s oral TYK2 inhibitor clears phase 3 psoriasis test
fiercebiotech
Jul 24, 26
Sanofi halts development of troubled immune drug in eczema
biopharma dive
Jul 24, 26
Sanofi’s $1.4B Kymab bet falters again as atopic dermatitis trials scrapped
biospace
Jul 24, 26
Sanofi nixes Kymab-originated OX40L antibody in atopic dermatitis
endpoints
Jul 24, 26
FDA panel endorses broader use of certain peptides
biopharma dive
Jul 22, 26
Arrowhead hits ‘best-case scenario’ with latest results for fat-lowering drug
biopharma dive
Jul 22, 26
STAT+: Pharma tries to tamp down broad China restrictions
stat
Jul 22, 26
Summit counters PD-1/VEGF skeptics; Celldex drug fails skin disease study
biopharma dive
Jul 22, 26
Celldex scraps antibody in prurigo nodularis after Phase 2 flop
endpoints
Jul 22, 26
As Maui recovers from devastating fires, a study offers vision for new rural health model
stat
Jul 22, 26
Celldex ends skin disease program after failing phase 2 test
fiercebiotech
Jul 17, 26
Arbutus, Sanofi escalate mRNA patent fights; InnoCare’s TYK2 contender advances
biopharma dive
Jul 16, 26
Braveheart, Attovia, Vogenx keep IPOs ballooning with plans to compete in cardiometabolic, immuno
biospace
Jul 16, 26
Takeda’s zasocitinib proves ‘top-notch’ for difficult-to-treat psoriasis in phase 3 update
fiercebiotech
Jul 16, 26
Racing Takeda, InnoCare reports TYK2 inhibitor win in phase 2 vitiligo trial
fiercebiotech
Jul 16, 26
Opinion: The growing fang-to-pharmacy pipeline
stat
Jul 13, 26
STAT+: Pharmalittle: We’re reading about an RFK Jr. push against psychiatric meds, a Sanofi blood cancer drug, and more
stat
Jul 10, 26
ARPA-H puts $160M into bespoke drug therapies; Biohaven switches up scientific leadership
biopharma dive
Jul 9, 26
Opinion: Your grandparents are using cannabis. Doctors can help them do it safely
stat
Jul 8, 26
Are glucose monitors a good thing for 2-year-olds? Experts look at risks, benefits
stat
← prev
page 6 of 8
next →